Type 1 Diabetes Fellows Series

May 11, 2023

The application for the 10th annual installment of Endocrine Society’s Type 1 Diabetes Fellows series is now closed. Applicants will receive notifications and more details in early April. Have questions? Please contact [email protected] for assistance.

For ten years, this program has sought to address skill and workforce gaps by providing comprehensive education on type 1 diabetes care while also strengthening the network of next generation endocrinologists.

This year the Type 1 Diabetes Fellows Conference will have two core components:

45-minute on-demand didactic sessions; and
A prestigious, in-person meeting held in Chicago June 13-14, ahead of ENDO, where fellows get the exclusive opportunity to meet with experts in T1D and product demonstrations with industry representatives.

Fellows that are invited to attend the in-person meeting will receive complimentary registration to ENDO 2023, as well as a travel stipend.

In-person Meeting Schedule:

Early Spring 2023	On-Demand Didacticsessions launch
June 13, 2023	Welcome Reception Dinner Keynote Address with Q&A Product Showcase
June 14, 2023	Lectures Small group and lunch discussions with faculty Breakout sessions

T1D Fellows Agenda

Tuesday, June 13, 2023

6:00-6:30 PM	Welcome Reception
6:30-7:00 PM	Dinner
7:00-7:45 PM	Keynote Address: Cheating Destiny: Living with Diabetes, America's Biggest Epidemic James S. Hirsch
7:45-8:00 PM	Q&A
8:00-9:00 PM	Product Showcase

Wednesday, June 14, 2023

7:00-8:00 AM	Registration and Breakfast with the Faculty
8:00-8:10 AM	Welcoming Remarks Irl B. Hirsch, MD, University of Washington Davida F. Kruger, MSN, APN-BC, BC-ADM, Henry Ford Health
8:10-8:50 AM	Closing the Loop with Diabetes Technology CGM Use and Interpretation with MDI Viral Shah, MD, University of Colorado
8:50-9:30 AM	Closing the Loop with Diabetes Technology CGM Use and Interpretation with Open Loop Anne Peters, MD, USC Westside Center for Diabetes
9:30-10:10 AM	Closing the Loop with Diabetes Technology CGM Use and Interpretation with Closed Loop Irl B. Hirsch, MD, University of Washington
10:10-10:40 AM	Break & Questions for Industry Representatives
10:40-11:55 AM	Small Group Discussions Sick Day Faisal S. Malik, MD, MSHS, Seattle Children’s Hospital In-Patient Management Alexis McKee, MD, CDCES, Washington University School of Medicine in St. Louis T1D in Underserved Populations Lorena Wright, MD, FACE, University of Washington Implementing Realistic Nutrition Therapy for People with Type 1 Diabetes Patti Urbanski, MEd, RD, LD, CDE, St. Luke's Duluth Exercise Management: Considerations and Strategies for T1D Michael C. Riddell, PhD, York University Tidepool Loop and Expanding Closed Loop Access Howard Look, Tidepool
11:55 AM-12:55 PM	Lunch Discussion with Faculty
12:55-1:35 PM	Biostatistics for the Clinical Endocrinologist Roy W. Beck, MD, PhD, Jaeb Center for Health Research
1:35-2:15 PM	Novel Immune Therapy Carla J. Greenbaum, MD, Benaroya Research Institute
2:15-2:45 PM	Break & Questions for Industry Representatives
2:45-4:00 PM	Small Group Discussion: Identifying and Confronting Challenging Transitions Faisal S. Malik, MD, MSHS, Seattle Children’s Hospital In-Patient Management Alexis McKee, MD, CDCES, Washington University School of Medicine in St. Louis T1D in Underserved Populations Lorena Wright, MD, FACE, University of Washington Implementing Realistic Nutrition Therapy for People with Type 1 Diabetes Patti Urbanski, MEd, RD, LD, CDE, St. Luke's Duluth Exercise Management: Considerations and Strategies for T1D Michael C. Riddell, PhD, York University Tidepool Loop and Expanding Closed Loop Access Howard Look, Tidepool
4:00-4:40 PM	Fresh Look at Insulin Dr. Bernard Zinman, FRCP, FACP, MD, Mount Sinai Hosp, University of Toronto
4:40-5:00 PM	Closing Comments Irl B. Hirsch, MD, University of Washington Davida F. Kruger, MSN, APN-BC, BC-ADM, Henry Ford Health

2023 Learning Objectives

Upon successful completion these educational initiatives, participants should be better able to:

Discuss the prevalence and progression of type 1 diabetes to recognize signs and differentially diagnose diabetes
Devise individualized treatment strategies that use new and emerging insulin therapies to manage individuals with type 1 diabetes with and without common comorbid conditions.
Incorporate diabetes technologies, including insulin pump therapy and continuous glucose monitoring, into treatment strategies for appropriate individuals with type 1 diabetes and evaluate data from those technologies.
Recognize and evaluate individuals with type 1 diabetes for signs of depression and distress using updated guidelines and practice tools.
Apply updated knowledge of treatments, practice guidelines, and clinical skills to improve care, long-term outcomes, and sick day management of individuals with type 1 diabetes.
Describe current and emerging therapy for the treatment of pre-clinical type 1 diabetes
Discuss various strategies for exercise and minimizing hypoglycemia for individuals with T1D

Last Updated: May 11, 2023